Single dose of 1% tropicamide and 10% phenylephrine for pupil dilation. 2006

Tanapat Ratanapakorn, and Yosanan Yospaiboon, and Natthira Chaisrisawadsuk
Department of Ophthalmology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand. yosanan@kku.ac.th

OBJECTIVE To compare the efficacy of pupil dilation between a single dose and three doses of 1% tropicamide and 10% phenylephrine for binocular indirect ophthalmoscopy. METHODS A prospective randomized double-blind clinical controlled trial was conducted. All patients underwent the binocular indirect ophthalmoscopy and met the inclusion criteria were randomized into two groups using block randomization. Group A received a single dose of 1% tropicamide and 10% phenylephrine eye drops, and Group B received three doses of the same drugs. The primary outcome was the horizontal pupil diameter measured by slit-lamp biomicroscope (Haag-Streit model 900) before and at 10, 15, 20, 25 and 30 minutes after eye drop instillation. The clinical equivalence of the efficacy of pupil dilation between the two groups was defined as the difference of less than or equal to 1 mm (-1 mm to + 1 mm). RESULTS Eighty patients (160 eyes) were randomized into 40 patients (80 eyes) in group A and 40 patients (80 eyes) in group B. The mean pupil sizes at baseline of group A were 3.51 +/- 0.63 mm in the right eye and 3.39 +/- 0.67 mm in the left eye. Those in group B were 3.61 +/- 0.67 mm in the right eye and 3.66 +/- 0.72 mm in the left eye. The mean pupil diameters at 30 minutes of group A were 7.34 +/- 0.51 mm in the right eye and 7.41 +/- 0.56 mm in the left eye, whereas those of group B were 7.49 +/- 0.45 mm in the right eye and 7.51 +/- 0.40 mm in the left eye. The mean difference of the pupil size between the two groups was 0.15 mm (p = 0.175) in the right eye and 0.l0 mm (p = 0.362) in the left eye. The 95% confidence intervals of the difference in pupil size were -0.36 to 0.07 mm in the right eye and -0.32 to 0.12 mm in the left eye. CONCLUSIONS The 95% confidence interval of the difference in pupil size lay entirely within the range of equivalence. The single dose of 1% tropicamide and 10% phenylephrine was clinically equivalent to the three doses of the same drugs.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009184 Mydriatics Agents that dilate the pupil. They may be either sympathomimetics or parasympatholytics. Cycloplegic,Cycloplegics,Mydriatic,Mydriatic Effect,Mydriatic Effects,Effect, Mydriatic,Effects, Mydriatic
D009883 Ophthalmic Solutions Sterile solutions that are intended for instillation into the eye. It does not include solutions for cleaning eyeglasses or CONTACT LENS SOLUTIONS. Eye Drop,Eyedrop,Eyedrops,Ophthalmic Solution,Eye Drops,Drop, Eye,Drops, Eye,Solution, Ophthalmic,Solutions, Ophthalmic
D009887 Ophthalmoscopy Examination of the interior of the eye with an ophthalmoscope. Ophthalmoscopies
D010656 Phenylephrine An alpha-1 adrenergic agonist used as a mydriatic, nasal decongestant, and cardiotonic agent. (R)-3-Hydroxy-alpha-((methylamino)methyl)benzenemethanol,Metaoxedrin,Metasympatol,Mezaton,Neo-Synephrine,Neosynephrine,Phenylephrine Hydrochloride,Phenylephrine Tannate,Neo Synephrine,Tannate, Phenylephrine
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D011680 Pupil The aperture in the iris through which light passes. Pupils
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked

Related Publications

Tanapat Ratanapakorn, and Yosanan Yospaiboon, and Natthira Chaisrisawadsuk
July 1985, American journal of optometry and physiological optics,
Tanapat Ratanapakorn, and Yosanan Yospaiboon, and Natthira Chaisrisawadsuk
January 1999, Ophthalmology,
Tanapat Ratanapakorn, and Yosanan Yospaiboon, and Natthira Chaisrisawadsuk
April 1998, Ophthalmology,
Tanapat Ratanapakorn, and Yosanan Yospaiboon, and Natthira Chaisrisawadsuk
March 2017, Acta ophthalmologica,
Tanapat Ratanapakorn, and Yosanan Yospaiboon, and Natthira Chaisrisawadsuk
July 1997, Archives of neurology,
Tanapat Ratanapakorn, and Yosanan Yospaiboon, and Natthira Chaisrisawadsuk
January 2009, Ophthalmic research,
Tanapat Ratanapakorn, and Yosanan Yospaiboon, and Natthira Chaisrisawadsuk
January 1997, Pharmacopsychiatry,
Tanapat Ratanapakorn, and Yosanan Yospaiboon, and Natthira Chaisrisawadsuk
October 1986, American journal of optometry and physiological optics,
Tanapat Ratanapakorn, and Yosanan Yospaiboon, and Natthira Chaisrisawadsuk
December 2019, Ophthalmic epidemiology,
Tanapat Ratanapakorn, and Yosanan Yospaiboon, and Natthira Chaisrisawadsuk
June 2000, Eye (London, England),
Copied contents to your clipboard!